Navidea Biopharmaceuticals, Inc. Skyrocketed
Fri, Dec 01, 2023 at 07:42 PM
Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) shot up at $0.07, a gain of 39.5%. On Fri, Dec 01, 2023, NAVB:NYSEMKT touched a New 2-Week Intraday Low of $0.05. The stock appeared on our News Catalysts scanner on Fri, Dec 01, 2023 at 11:44 AM in the 'AGREEMENT' category. From Fri, Nov 17, 2023, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Thu, Sep 14, 2023 at $0.15 with a volume of 22M+.
About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
Top 10 Gainers:
- Kubient Inc. (KBNT:NASDAQ), 175%
- NexImmune Inc. (NEXI:NASDAQ), 144.94%
- Green Giant Inc Com (New) (GGE:NASDAQ), 66.43%
- View Inc. (VIEW:NASDAQ), 63.26%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 59.76%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 52.07%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 50.68%
- Newegg Commerce Inc. (NEGG:NASDAQ), 42.86%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 39.52%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 39.05%